Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Duncan

Showing results (861-870 of 889) with videos related to

Pageof 89
Sort By:
BMC Health Services Research|December 21, 2019
Implementation of a billable transitional care model for stroke patients: the COMPASS studySabina B Gesell, Cheryl D Bushnell, Sara B Jones, et al.
Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Cancer|May 5, 2016
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemiaJessica R Galloway-Peña, Daniel P Smith, Pranoti Sahasrabhojane, et al.
BMJ Open|May 29, 2021
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' studyNirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Communications Biology|April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitorGordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care PlansPamela W Duncan, Rica M Abbott, Scott Rushing, et al.
The New England Journal of Medicine|April 20, 2010
Robot-assisted therapy for long-term upper-limb impairment after strokeAlbert C Lo, Peter D Guarino, Lorie G Richards, et al.
Cell Reports|June 4, 2020
Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem CellsKazuki Takeishi, Alexandra Collin de l'Hortet, Yang Wang, et al.
BMC Neurology|July 19, 2017
The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trialPamela W Duncan, Cheryl D Bushnell, Wayne D Rosamond, et al.
Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.
Pageof 89

Showing results (861-870 of 889) with videos related to

Sort By:
Pageof 89
BMC Health Services Research|December 21, 2019
Implementation of a billable transitional care model for stroke patients: the COMPASS studySabina B Gesell, Cheryl D Bushnell, Sara B Jones, et al.
Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Cancer|May 5, 2016
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemiaJessica R Galloway-Peña, Daniel P Smith, Pranoti Sahasrabhojane, et al.
BMJ Open|May 29, 2021
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' studyNirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Communications Biology|April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitorGordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care PlansPamela W Duncan, Rica M Abbott, Scott Rushing, et al.
The New England Journal of Medicine|April 20, 2010
Robot-assisted therapy for long-term upper-limb impairment after strokeAlbert C Lo, Peter D Guarino, Lorie G Richards, et al.
Cell Reports|June 4, 2020
Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem CellsKazuki Takeishi, Alexandra Collin de l'Hortet, Yang Wang, et al.
BMC Neurology|July 19, 2017
The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trialPamela W Duncan, Cheryl D Bushnell, Wayne D Rosamond, et al.
Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.
Pageof 89